Nakesha J. Jackson
FDA investigator
Appears on 1 document from 2021, mostly at sites in Florida. Most often cites written procedures; deviations (21 CFR 211.100).
- 1
- Documents on file
- 4.0
- Observations per 483
- 2021
- First seen
- 2021
- Most recent
What they cite most
From 4 observations- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.115Reprocessing1
- 21 CFR 211.80General requirements1
- 21 CFR 820.100Corrective and preventive action1
Activity by year
2021: 1
Where
Florida 1
Often inspects with
Is Nakesha J. Jackson coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2021-11-05 | 483 B. Braun US Pharmaceutical Manufacturing LLCNov 5, 2021 · Daytona Beach, Florida | Daytona Beach, Florida | 4 |
About this profile
What does Nakesha J. Jackson inspect?
Nakesha J. Jackson appears on 1 document on file covering 1 site, mostly in Florida.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.115 and 21 CFR 211.80.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Nakesha J. Jackson is dated Nov 5, 2021.